Dashboard
Manage Tickers

CLXPF CYBIN INC.

NYSE cybin.com


$ 6.06 $ 0.12 (2.02 %)    

Thursday, 06-Nov-2025 15:59:53 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.36 $ -9.99 (-1.61 %)
DIA $ 470.23 $ -2.78 (-0.59 %)
SPY $ 671.96 $ -6.30 (-0.93 %)
TLT $ 89.61 $ 0.21 (0.23 %)
GLD $ 367.27 $ -1.11 (-0.3 %)
$ 6.07
$ 5.95
$ 5.82 x 260
$ 6.14 x 4
$ 5.82 - $ 6.15
$ 4.81 - $ 13.88
880,216
na
131.12M
$ 0.74
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

what-do-you-really-know-about-psychedelics-and-psychedelics-stocks
What Do You Really Know About Psychedelics...
08/11/2021 15:18:16

According to a new poll conducted by Hill-HarrisX, 65% of registered voters say psychedelic substances do not have medical use.

psychedelics-research-fyi-every-clinical-trial-underway-right-now-involving-public-and-private-companies
Psychedelics Research FYI: Every Clinical ...
08/03/2021 18:23:57

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In jus...

psyched-field-trip-uplists-to-nasdaq-mindmed-to-study-dmt-atai-launches-new-subsidiary-aocs-psychedelics-amendment-rejected
Psyched: Field Trip Uplists To Nasdaq, Min...
08/02/2021 14:08:33

Last week in Psychedelics:

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
07/26/2021 14:05:18

 

Core News & Articles
HC Wainwright & Co. Initiates Coverage On ...
07/26/2021 13:36:42

HC Wainwright & Co. analyst Patrick Trucchio initiates coverage on Cybin (OTC:CLXPF) with a Buy rating and announces Pri...

psyched-cybin-and-field-trip-head-to-wall-street-aoc-pushes-for-federal-psychedelics-research-off-label-ketamine-covered-by-insurance-in-canada
Psyched: Cybin And Field Trip Head To Wall...
07/26/2021 12:02:09

Cybin Inc.

cybin-lands-conditional-approval-to-become-the-first-psychedelics-company-on-the-nyse
Cybin Lands Conditional Approval To Become...
07/22/2021 18:03:49

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF), a biotech company in the psychedelics space, announced on Thursday a conditional approva...

psyched-numinus-mindmed-cybin-reach-milestones-harvard-to-study-psychedelics-law-michael-pollan-dives-into-mescaline
Psyched: Numinus, MindMed, Cybin Reach Mil...
07/12/2021 12:41:59

Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of Mesc...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
07/08/2021 14:03:41

 

Core News & Articles
Aegis Capital Initiates Coverage On Cybin ...
07/08/2021 13:33:37

Aegis Capital analyst Nathan Weinstein initiates coverage on Cybin (OTC:CLXPF) with a Buy rating and announces Price Target ...

psyched-gh-research-debuts-on-nasdaq-compass-reaches-psilocybin-research-milestone-maxim-gives-buy-rating-to-10-psychedelics-companies
Psyched: GH Research Debuts on Nasdaq, Com...
07/02/2021 20:20:48

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT f...

maxim-group-gives-buy-rating-to-10-psychedelic-stocks-compass-mindmed-cybin-field-trip-and-more
Maxim Group Gives Buy Rating To 10 Psyched...
06/30/2021 22:14:36

Institutional analysts are taking a liking to the industry of medicinal psychedelics. This week, investment bank Maxim Group in...

psyched-atai-life-sciences-hits-nasdaq-canada-to-fund-ketamine-trials-mydecine-launches-ai-drug-discovery-platform
Psyched: Atai Life Sciences Hits Nasdaq, C...
06/21/2021 14:21:54

Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq debut on Friday.

psyched-atais-214m-ipo-mindmed-ceo-resigns-field-trip-applies-to-nasdaq-cybin-and-novamind-target-frontline-health-workers
Psyched: Atai's $214M IPO, MindMed CEO Res...
06/14/2021 13:18:12

Atai Launches $214 Million Nasdaq IPO Offering Psychedelics biotech platform Atai life Sciences has announced an initial publi...

cybin-to-co-sponsor-clinical-trial-testing-psilocybin-in-frontline-health-workers-with-covid-related-distress
Cybin To Co-Sponsor Clinical Trial Testing...
06/08/2021 21:15:21

Psychedelics and biotech company Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) is co-sponsoring a new clinical trial that will test the...

Core News & Articles
Cybin Launches EMBARK and Co-Sponsors Firs...
06/08/2021 11:09:55

Cybin Inc.

psyched-first-psychedelics-etf-comes-to-the-us-bills-move-forward-in-texas-california-and-new-york
Psyched: First Psychedelics ETF Comes To T...
06/07/2021 10:51:21

Psychedelics ETFs Are Gaining Traction Defiance ETFs launched the “Next Gen Altered Experience ETF,” the first U.S.-listed ETF...

Core News & Articles
Cannabis Countdown: Top 10 Marijuana and P...
05/27/2021 13:17:57

Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap.

psyched-mindmed-to-begin-mescaline-trials-and-deepak-chopra-partnership-seelos-and-cybin-advance-clinical-research
Psyched: MindMed To Begin Mescaline Trials...
05/24/2021 12:33:14

MindMed’s News Spree: Mescaline Trials, Chopra Foundation Partnership and LSD Research

cannabis-countdown-top-10-marijuana-and-psychedelic-stock-news-stories-of-the-week
Cannabis Countdown: Top 10 Marijuana And P...
05/19/2021 14:27:06

Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION